Application of Intracranial Pressure-Directed Therapy on Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
Jun Yang, Junlin Lu, Runting Li, Fa Lin, Yu Chen, Heze Han, Debin Yan, Ruinan Li, Zhipeng Li, Haibin Zhang, Kexin Yuan, Hongliang Li, Linlin Zhang, Guangzhi Shi, Jianxin Zhou, Shuo Wang, Yuanli Zhao, Xiaolin Chen, Jun Yang, Junlin Lu, Runting Li, Fa Lin, Yu Chen, Heze Han, Debin Yan, Ruinan Li, Zhipeng Li, Haibin Zhang, Kexin Yuan, Hongliang Li, Linlin Zhang, Guangzhi Shi, Jianxin Zhou, Shuo Wang, Yuanli Zhao, Xiaolin Chen
Abstract
Objective: Elevated ICP is a well-recognized phenomenon in aneurysmal subarachnoid hemorrhage (aSAH) that has been demonstrated to lead to poor outcomes. Delayed cerebral ischemia (DCI) is the most important reason for a poor clinical outcome after a subarachnoid hemorrhage. DCI is understood as a multifactorial process that evolves over time, largely caused by the sequelae of increased intracranial pressure (ICP). The study aimed to assess how to better define the association between ICP and DCI, and whether rational ICP management can improve the outcome of aSAH patients.
Methods: We prospectively reviewed patients diagnosed with aSAH and received microsurgery clipping at our department from December 2019 to January 2021. Subdural ICP monitoring devices were kept to monitor the ICP. The ICP values were recorded every 1-h epochs. ICP -guided dehydration treatments were routinely performed to control the ICP level of patients after surgery. To evaluate whether the subdural ICP-directed management improved the prognosis of the aSAH patients, we compared the outcome data of the patients in our cohort with those treated at another ward of our hospital at the same period.
Results: In total, 144 consecutive aSAH patients received microsurgery clipping at our department, 68 of whom underwent ICP monitoring. A total of 11,424 1-h ICP measurements were recorded for the included patients (1.30 years of recordings). Of 68 patients with ICP monitoring, 27 (27/68, 39.7%) patients developed DCI. Univariate analysis showed that higher Hunt-Hess grade (OR 2.138, 95% CI 1.025-4.459, p = 0.043), higher preoperative modified Rankin Scale score (OR 1.534, 95% CI 1.033-2.276, p = 0.034), and the max ICP value of each day value >28.5 mmHg (OR 4.442, 95% CI 1.509-13.082, p = 0.007) were associated with DCI. Also, patients with ICP-directed treatment showed a significantly lower DCI incidence than patients without ICP monitoring.
Conclusion: Our study suggests that I less than 15 mmHg possibly constitute normal values and that 28.5 mmHg is the ICP threshold most strongly associated with the occurrence of DCI in aSAH patients. Patients who received the ICP-directed treatment presented a lower incidence of DCI. Our findings provide a basis for the recommendation of ICP-directed treatment after aSAH.
Trial registration number: NCT04785976.
Keywords: aneurysmal subarachnoid hemorrhage; dehydration; delayed cerebral ischemia; delayed neurological deterioration; intracranial pressure.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Copyright © 2022 Yang, Lu, Li, Lin, Chen, Han, Yan, Li, Li, Zhang, Yuan, Li, Zhang, Shi, Zhou, Wang, Zhao and Chen.
Figures
References
- Alotaibi N. M., Wang J. Z., Pasarikovski C. R., Guha D., Al-Mufti F., Mamdani M., et al. (2017). Management of raised intracranial pressure in aneurysmal subarachnoid hemorrhage: time for a consensus? Neurosurg. Focus 43 E13. 10.3171/2017.7.FOCUS17426
- Czosnyka M., Pickard J. D. (2004). Monitoring and interpretation of intracranial pressure. J. Neurol. Neurosurg. Psychiatry 75 813–821.
- Dodd W. S., Laurent D., Dumont A. S., Hasan D. M., Jabbour P. M., Starke R. M., et al. (2021). Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review. J. Am. Heart Assoc. 10:e021845. 10.1161/JAHA.121.021845
- Florez W. A., Garcia-Ballestas E., Deora H., Agrawal A., Martinez-Perez R., Galwankar S., et al. (2021). Intracranial hypertension in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg. Rev. 44 203–211. 10.1007/s10143-020-01248-9
- Fukuhara T., Douville C. M., Eliott J. P., Newell D. W., Winn H. R. (1998). Relationship between intracranial pressure and the development of vasospasm after aneurysmal subarachnoid hemorrhage. Neurol. Med. Chir. 38 710–7155; discussion 716–717. 10.2176/nmc.38.710
- Hawryluk G. W. J., Nielson J. L., Huie J. R., Zimmermann L., Saigal R., Ding Q., et al. (2020a). Analysis of normal high-frequency intracranial pressure values and treatment threshold in neurocritical care patients: insights into normal values and a potential treatment threshold. JAMA Neurol. 77 1150–1158. 10.1001/jamaneurol.2020.1310
- Hawryluk G. W. J., Rubiano A. M., Totten A. M., O’Reilly C., Ullman J. S., Bratton S. L., et al. (2020b). Guidelines for the management of severe traumatic brain injury: 2020 update of the decompressive craniectomy recommendations. Neurosurgery 87 427–434.
- Hayashi T., Suzuki A., Hatazawa J., Kanno I., Shirane R., Yoshimoto T., et al. (2000). Cerebral circulation and metabolism in the acute stage of subarachnoid hemorrhage. J. Neurosurg. 93 1014–1018. 10.3171/jns.2000.93.6.1014
- Lee K. H., Lukovits T., Friedman J. A. (2006). “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit. Care 4 68–76.
- Macdonald R. L., Schweizer T. A. (2017). Spontaneous subarachnoid haemorrhage. Lancet 389 655–666.
- Marshall L. F., Smith R. W., Shapiro H. M. (1979). The outcome with aggressive treatment in severe head injuries. Part I: the significance of intracranial pressure monitoring. J. Neurosurg. 50 20–25. 10.3171/jns.1979.50.1.0020
- Roos Y. B., de Haan R. J., Beenen L. F., Groen R. J., Albrecht K. W., Vermeulen M. (2000). Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J. Neurol. Neurosurg. Psychiatry 68 337–341. 10.1136/jnnp.68.3.337
- Siler D. A., Gonzalez J. A., Wang R. K., Cetas J. S., Alkayed N. J. (2014). Intracisternal administration of tissue plasminogen activator improves cerebrospinal fluid flow and cortical perfusion after subarachnoid hemorrhage in mice. Transl. Stroke Res. 5 227–237. 10.1007/s12975-014-0329-y
- Sorrentino E., Diedler J., Kasprowicz M., Budohoski K. P., Haubrich C., Smielewski P., et al. (2012). Critical thresholds for cerebrovascular reactivity after traumatic brain injury. Neurocrit. Care 16 258–266. 10.1007/s12028-011-9630-8
- Stienen M. N., Germans M., Burkhardt J. K., Neidert M. C., Fung C., Bervini D., et al. (2018). Predictors of in-hospital death after aneurysmal subarachnoid hemorrhage: analysis of a nationwide database (Swiss SOS [Swiss study on aneurysmal subarachnoid hemorrhage]). Stroke 49 333–340. 10.1161/strokeaha.117.019328
- Topkoru B., Egemen E., Solaroglu I., Zhang J. H. (2017). Early brain injury or vasospasm? An overview of common mechanisms. Curr. Drug Targets 18 1424–1429. 10.2174/1389450117666160905112923
- Wang X., Chen J. X., Mao Q., Liu Y. H., You C. (2014). Relationship between intracranial pressure and aneurysmal subarachnoid hemorrhage grades. J. Neurol. Sci. 346 284–287. 10.1016/j.jns.2014.09.011
Source: PubMed